Literature DB >> 18773392

A linear index for predicting joint health-states utilities from single health-states utilities.

Anirban Basu1, William Dale, Arthur Elstein, David Meltzer.   

Abstract

Direct elicitation of utilities for joint health (JS) states may pose substantial interview burden, while traditional models to predict these utilities from utilities of component single states (SS) are inconsistent with the data. Using individual-level data on utilities for health states associated with prostate cancer, we report the performance of a new model that encompasses three traditional models - additive, multiplicative, and minimum - previously used for predicting utilities for joint health states. Describing utilities in terms of utility losses l(.) relative to prefect health, our final estimated linear index for predicting joint health-state utilities is El(JS)=0.05+0.72 x max l(SS1),l(SS2)+0.33.min x l(SS1),l(SS2)-0.18 x l(SS1) x l(SS2). Based on out-of-sample predictions, this model produces up to 50% reduction in mean-square error compared with traditional models and consistent prediction across different ranges of joint-state utilities, which the traditional models do not. Parameter estimates of the new model proposed here provide direct evidence on the inconsistencies of the traditional models, are grounded in psychological theory by emphasizing the more severe component of a joint health state, and provide a simple linear index to generate consistent predictions of utilities for joint health states. Further validation of this function for joint health states in other clinical scenarios is warranted. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 18773392     DOI: 10.1002/hec.1373

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

1.  The impact of co-morbidity burden on preference-based health-related quality of life in the United States.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Elizabeth A Bayliss
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

2.  A value set for the EQ-5D based on experienced health states: development and testing for the German population.

Authors:  Reiner Leidl; Peter Reitmeir
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

3.  Sourcing quality-of-life weights obtained from previous studies: theory and reality in Korea.

Authors:  SeungJin Bae; Eun Young Bae; Sang Hee Lim
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  Joint Utility Estimators in Substance Use Disorders.

Authors:  Eve Wittenberg; Jeremy W Bray; Achamyeleh Gebremariam; Brandon Aden; Bohdan Nosyk; Bruce R Schackman
Journal:  Value Health       Date:  2016-11-17       Impact factor: 5.725

5.  Examining the relationship between health-related quality of life and increasing numbers of diagnoses.

Authors:  Mathias Barra; Liv Ariane Augestad; David G T Whitehurst; Kim Rand-Hendriksen
Journal:  Qual Life Res       Date:  2015-06-12       Impact factor: 4.147

Review 6.  A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016.

Authors:  Anne Magnus; Wanrudee Isaranuwatchai; Cathrine Mihalopoulos; Victoria Brown; Rob Carter
Journal:  MDM Policy Pract       Date:  2019-05-27

7.  Cost burden and net monetary benefit loss of neonatal hypoglycaemia.

Authors:  Matthew J Glasgow; Richard Edlin; Jane E Harding
Journal:  BMC Health Serv Res       Date:  2021-02-05       Impact factor: 2.655

8.  Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.

Authors:  M T Pho; D M Jensen; D O Meltzer; A Y Kim; B P Linas
Journal:  J Viral Hepat       Date:  2015-08       Impact factor: 3.517

9.  Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer.

Authors:  Karen M Kuntz; Jonah Popp; J Robert Beck; Ann G Zauber; David S Weinberg
Journal:  BMJ Open Gastroenterol       Date:  2020-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.